鼻咽癌
诱导化疗
肿瘤科
化疗
医学
内科学
放射治疗
作者
Pei Huang,Xu-Yin Chen,Xi Ding,Ling Guo,Hao Mo,Xiong Zou,Chong-yang Duan,Ling Li,Rui You,Xiao Yang,You-Ping Liu,YuLong Xie,Yi-Nuan Zhang,Jingyu Cao,Sihan Liu,Zi-Meng Wang,Qi Yang,Chao Lin,Si-Yuan Chen,Yan‐Feng Ouyang
出处
期刊：NEJM evidence
[New England Journal of Medicine]
日期：2025-04-22
卷期号：4 (5): EVIDoa2400214-EVIDoa2400214
被引量：4
标识
DOI：10.1056/evidoa2400214
摘要
For 2-year FFS for LA-NPC, gemcitabine and cisplatin IC plus IMRT alone was noninferior to CCRT. (Funded by Key-Area Research and Development of Guangdong Province and others.).
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
嘻嘻哈哈
cdercder
无极微光
AllRightReserved
GingerF
369ninja
lalala
栗子
iNk
arniu2008
科研狗
Nexus
昏睡的蟠桃
光明磊落陈2011
Sea_U
eric888
ffrrss
丁丁当当
MchemG
糊涂的雅琴
皖公网安备34019202002308
